PHILADELPHIA, Pennsylvania — A combination of dextromethorphan and quinidine (Nuedexta, Avanir Pharmaceuticals) significantly reduced symptoms of pseudobulbar affect (PBA) among patients with dementia ...

ALISO VIEJO, Calif., August 11, 2009 - AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced that the investigational drug Zenvia™ (dextromethorphan/quinidine ...

CA_092018_Feature-2_Image Pseudobulbar affect is a significant national health issue in the United States, with approximately 2 million individuals affected. Pseudobulbar affect is characterized by ...

Laughing and crying are normal human responses to emotion, but when it becomes sudden, frequent, uncontrollable and doesn’t match how you feel, it might be a sign of a medical condition called ...

Have you ever heard of pseudobulbar affect or PBA? If you answered no, you're not alone. Charles Darwin first described this health condition now known as PBA more than 130 years ago, but many ...

This article is sponsored by Otsuka America Pharmaceutical, Inc. In long-term care environments, it’s not uncommon for site staff including nurses, administrators, physical therapists, physicians and ...

Some people with Lewy body dementia (LBW) develop a symptom called pseudobulbar affect (PBA), which can lead to uncontrollable crying or laughter. Around 20–30% of people with dementia receive a ...

(ARA) - Imagine not being able to control when you laughed or when you cried. While it's not a well-known condition, this is reality for those who suffer from pseudobulbar affect (PBA), which is ...

ALISO VIEJO, Calif., October 9, 2009 - AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced additional detailed results from the confirmatory double-blind Phase III STAR trial evaluating two ...